Telmisartan/HCTZ

DRUG3 trials

Sponsors

Boehringer Ingelheim

Conditions

HealthyHypertension

Phase 1

Pharmacokinetics of Different Formulations of Telmisartan, Amlodipine, and Hydrochlorothiazide (HCTZ) in Japanese Healthy Male Volunteers

CompletedNCT02183675

Boehringer IngelheimHealthy

Start: 2014-07-31End: 2014-10-31Updated: 2016-11-30

Phase 3

Combination of Telmisartan 80 mg Plus Hydrochlorothiazide 12.5 mg to Telmisartan 80 mg in Patients Failed in Telmisartan 80 mg

CompletedNCT00146341

Boehringer IngelheimHypertension

Start: 2005-04-30End: 2006-09-30Updated: 2017-12-28

Study to Evaluate the Trough and Peak Effect of Once Daily Telmisartan 80 mg/Hydrochlorothiazide 12.5 mg (Micardis Plus) by Ambulatory Blood Pressure Monitoring (ABPM) in Patients With Mild to Moderate Essential Hypertension

CompletedNCT00257491

Boehringer IngelheimHypertension

Start: 2005-11-30End: 2006-08-31Updated: 2013-11-11